- Coordinates
- PDB Format
- Method
- SOLUTION NMR
- Oligo State
- hetero-2-1-mer
- Ligands
- 64 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 16 x 17F: O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine(Non-functional Binders)(Non-covalent)
17F.11: 6 residues within 4Å:- Ligands: PCW.55, PCW.65, PCW.72, 17F.79, 17F.82, 17F.83
No protein-ligand interaction detected (PLIP)17F.34: 10 residues within 4Å:- Chain B: K.179
- Ligands: PCW.3, PCW.7, PCW.12, PCW.14, PCW.30, 17F.36, PCW.44, PCW.54, PCW.74
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:K.179
17F.35: 14 residues within 4Å:- Chain B: R.43
- Ligands: PCW.16, PCW.18, PCW.21, PCW.27, PCW.30, PCW.32, 17F.38, 17F.41, PCW.44, 17F.45, PCW.55, PCW.59, 17F.79
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:R.43, B:R.43
17F.36: 11 residues within 4Å:- Chain B: M.172
- Ligands: PCW.7, PCW.10, PCW.12, PCW.15, 17F.34, 17F.39, PCW.54, PCW.63, PCW.70, PCW.74
No protein-ligand interaction detected (PLIP)17F.37: 18 residues within 4Å:- Chain B: A.68, M.69, Q.72
- Ligands: PCW.1, PCW.6, PCW.9, PCW.12, PCW.13, PCW.17, PCW.19, PCW.23, PCW.30, PCW.32, 17F.41, EWS.48, PCW.74, PCW.75, PCW.76
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:M.69, B:Q.72
17F.38: 12 residues within 4Å:- Chain B: R.43
- Ligands: PCW.19, PCW.20, PCW.21, PCW.24, PCW.27, PCW.32, 17F.35, PCW.50, PCW.57, PCW.59, PCW.65
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.43
17F.39: 8 residues within 4Å:- Chain B: D.107
- Ligands: PCW.7, PCW.12, PCW.13, 17F.36, PCW.61, PCW.63, PCW.70
No protein-ligand interaction detected (PLIP)17F.40: 7 residues within 4Å:- Ligands: PCW.3, PCW.14, PCW.18, PCW.22, PCW.28, PCW.42, PCW.52
No protein-ligand interaction detected (PLIP)17F.41: 15 residues within 4Å:- Chain B: Q.72, R.75, T.76
- Ligands: PCW.9, PCW.12, PCW.13, PCW.23, PCW.30, PCW.32, 17F.35, 17F.37, EWS.48, PCW.53, PCW.61, PCW.75
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.72
17F.45: 8 residues within 4Å:- Ligands: PCW.18, PCW.31, 17F.35, PCW.43, PCW.53, PCW.55, PCW.73, 17F.79
No protein-ligand interaction detected (PLIP)17F.78: 6 residues within 4Å:- Ligands: PCW.24, PCW.49, PCW.50, PCW.56, PCW.57, 17F.80
No protein-ligand interaction detected (PLIP)17F.79: 7 residues within 4Å:- Ligands: 17F.11, PCW.18, PCW.30, 17F.35, 17F.45, PCW.55, PCW.73
No protein-ligand interaction detected (PLIP)17F.80: 5 residues within 4Å:- Chain C: Y.74
- Ligands: PCW.57, PCW.65, 17F.78, 17F.83
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.74
17F.81: 3 residues within 4Å:- Ligands: PCW.7, PCW.10, PCW.54
No protein-ligand interaction detected (PLIP)17F.82: 11 residues within 4Å:- Ligands: PCW.5, 17F.11, PCW.25, PCW.27, PCW.29, PCW.33, PCW.60, PCW.69, PCW.72, PCW.73, PCW.77
No protein-ligand interaction detected (PLIP)17F.83: 8 residues within 4Å:- Ligands: 17F.11, PCW.20, PCW.24, PCW.59, PCW.65, PCW.71, PCW.72, 17F.80
No protein-ligand interaction detected (PLIP)- 1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)
GNP.46: 23 residues within 4Å:- Chain B: A.13, V.14, G.15, V.16, G.17, K.18, S.19, A.20, F.30, V.31, D.32, E.33, Y.34, D.35, P.36, T.37, N.118, K.119, D.121, L.122, S.147, A.148, K.149
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:A.13, B:G.15, B:G.17, B:K.18, B:S.19, B:S.19, B:S.19, B:A.20, B:V.31, B:D.32, B:D.35, B:N.118, B:K.119, B:K.119, B:A.148, B:K.149
- Salt bridges: B:D.121
- pi-Stacking: B:F.30
- pi-Cation interactions: B:K.119
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x EWS: (2R,4S)-4-[(5-bromo-1H-indole-3-carbonyl)amino]-2-[(4-chlorophenyl)methyl]piperidin-1-ium(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fang, Z. et al., Inhibition of K-RAS4B by a Unique Mechanism of Action: Stabilizing Membrane-Dependent Occlusion of the Effector-Binding Site. Cell Chem Biol (2018)
- Release Date
- 2018-09-05
- Peptides
- Apolipoprotein A-I: AC
GTPase KRas: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
B
- Coordinates
- PDB Format
- Method
- SOLUTION NMR
- Oligo State
- hetero-2-1-mer
- Ligands
- 64 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 16 x 17F: O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine(Non-functional Binders)(Non-covalent)
- 1 x GNP: PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x EWS: (2R,4S)-4-[(5-bromo-1H-indole-3-carbonyl)amino]-2-[(4-chlorophenyl)methyl]piperidin-1-ium(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fang, Z. et al., Inhibition of K-RAS4B by a Unique Mechanism of Action: Stabilizing Membrane-Dependent Occlusion of the Effector-Binding Site. Cell Chem Biol (2018)
- Release Date
- 2018-09-05
- Peptides
- Apolipoprotein A-I: AC
GTPase KRas: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
B